Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH, Feller-Kopman D, Wise R, Biswal S.

Sci Transl Med. 2011 Apr 13;3(78):78ra32. doi: 10.1126/scitranslmed.3002042.

2.

NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.

Boutten A, Goven D, Artaud-Macari E, Boczkowski J, Bonay M.

Trends Mol Med. 2011 Jul;17(7):363-71. doi: 10.1016/j.molmed.2011.02.006. Epub 2011 Apr 1. Review.

PMID:
21459041
3.

Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.

Speert DP, Wong SY, Macdonald M, Sargeant R.

Behring Inst Mitt. 1997 Feb;(98):274-82. Review.

PMID:
9382751
4.

Alveolar macrophages in chronic obstructive pulmonary disease (COPD).

Barnes PJ.

Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL627-37. Review.

PMID:
15579256
5.

Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.

Alikhan MM, Lee FE.

Curr Opin Pulm Med. 2014 Mar;20(2):159-64. doi: 10.1097/MCP.0000000000000023. Review.

PMID:
24441573
6.

Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.

Moghaddam SJ, Ochoa CE, Sethi S, Dickey BF.

Int J Chron Obstruct Pulmon Dis. 2011;6:113-23. doi: 10.2147/COPD.S15417. Epub 2011 Jan 27. Review.

7.

Defective phagocytosis in airways disease.

Donnelly LE, Barnes PJ.

Chest. 2012 Apr;141(4):1055-1062. doi: 10.1378/chest.11-2348. Review.

PMID:
22474147

Supplemental Content

Support Center